Enhancement of cytotoxicity against Vero E6 cells persistently infected with SARS-CoV by Mycoplasma fermentans

Archives of Virology

Volumn 152, Issue 5, 2007, Pages 1019-1025

  Mizutani, Tetsuya ^a   Fukushi, S ^a   Kenri, T ^a   Sasaki, Y ^a   Ishii, K ^a   Endoh, D ^b   Zamoto, A ^a   Saijo, M ^a   Kurane, I ^a   Morikawa, S ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; CERCOPITHECUS; CYTOPATHOGENIC EFFECT; MICROBIOLOGY; MYCOPLASMA FERMENTANS; PATHOLOGY; PHYSIOLOGY; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VERO CELL; VIROLOGY;

ANIMALS; APOPTOSIS; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; MYCOPLASMA FERMENTANS; MYCOPLASMA INFECTIONS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VERO CELLS;

CORONAVIRUS; MYCOPLASMA FERMENTANS; SARS CORONAVIRUS;

EID: 34247478978     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-006-0924-7     Document Type: Article

References (25)

1. Bauer FA, Wear DJ, Angritt P, Lo SC (1991) Mycoplasma fermentans (incognitus strain) infection in the kidneys of patients with acquired immunodeficiency syndrome and associated nephropathy: a light microscopic, immunohistochemical, and ultrastructural study. Hum Pathol 22: 63-69
2. Chan PK, Tam JS, Lam CW, Chan E, Wu A, Li CK, Buckley TA, Ng KC, Joynt GM, Cheng FW (2003) Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 9: 1058-1063
3. Chan PK, To KF, Lo AW, Cheung JL, Chu I, Au FW, Tong JH, Tam JS, Sung JJJ, Ng HK (2004) Persistent infection of SARS coronavirus in colonic cells in vitro. J Med Virol 74: 1-7
4. Everitt E, Wohlfart C (1987) Spectrophotometric quantitation of anchorage-dependent cell numbers using extraction of naphthol blue-black-stained cellular protein. Anal Biochem 162: 122-129
5. Hong T, Wang JW, Sun YL, Duan SM, Chen LB, Qu JG et al. (2003) Chlamydia-like and coronavirus-like agents found in dead cases of atypical pneumonia by electron microscopy. Zhonghua Yi Xue Za Zhi 83: 632-636
6. Ishii K, Hasegawa H, Nagata N, Mizutani T, Morikawa S, Suzuki T, Taguchi F, Tashiro M, Takemori T, Miyamura T, Tsunetsugu-Yokota Y (2007) Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. Virology (in press)
7. Kenri T, Seto S, Horino A, Sasaki Y, Sasaki T, Miyata M (2004) Use of fluorescent-protein tagging to determine the subcellular localization of mycoplasma pneumoniae proteins encoded by the cytadherence regulatory locus. J Bacteriol 186: 6944-6955
8. Kovacic R, Launay V, Tuppin P, Lafeuillade A, Feuillie V, Montagnier L, Grau O (1996) Rsearch for the presence of six Mycoplasma species in peripheral blood mononuclear cells of subjects seropositive and seronegative for human immunodeficiency virus. J Clin Microbiol 34: 1808-1810
9. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W et al. (2003) Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362: 263-270
10. Marra MA, Jones SJM, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YSN, Khattra J, Asano JK, Barber SA, Chan SY et al. (2003) The genome sequence of the SARSassociated coronavirus. Science 300: 1399-1404
11. Mizutani T, Fukushi S, Iizuka D, Inanami O, Kuwabara M, Takashima H, Yanagawa H, Saijo M, Kurane I, Morikawa S (2006) Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cells. FEMS Immunol Microbiol 46: 236-243
12. Mizutani T, Fukushi S, Ishii K, Sasaki Y, Kenri T, Saijo M, Kanaji Y, Shirota K, Kurane I, Morikawa S (2006) Mechanisms of establishment of persistent SARS-CoV-infected cells. Biochem Biophys Res Commun 347: 261-265
13. Mizutani T, Fukushi S, Murakami M, Hirano T, Saijo M, Kurane I, Morikawa S (2004) Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells. FEBS Lett 577: 187-192
14. Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S (2004) Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells. Biochem Biophys Res Commun 319: 1228-1234
15. Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S (2004) Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells. Virology 327: 169-174
16. Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S (2005) JNK and PI3k/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells. Biochem Biophys Acta 1741: 4-10
17. Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S (2006) Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells. FEBS Lett 580: 1417-1424
18. Nevins JR, Leone G, DeGregori J, Jakoi L (1997) Role of the Rb/E2F pathway in cell growth control. J Cell Physiol 173: 233-236
19. Palacios G, Jabado O, Renwick N, Briese T, Lipkin WI (2005) Severe acute respiratory syndrome coronavirus persistence in Vero cells. Chin Med J (Engl) 118: 451-459
20. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH et al. (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300: 1394-1399
21. 4+ T lymphocytes. AIDS Res Hum Retrovir 9: 775-780
22. Shibata K, Sasaki T, Watanabe T (1995) AIDS-associated mycoplasmas possess phospholipases C in the membrane. Infect Immunol 63: 4174-4177
23. Shimizu T, Kida Y, Kuwano K (2004) Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors. Immunology 113: 121-129
24. Yamate M, Yamashita M, Goto T, Tsuji S, Li YG, Warachit J, Yunoki M, Ikuta K (2005) Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus. Microbes Infect 7: 1530-1540
25. Zahariadis G, Latchford MI, Ryall P, Hutchinson C, Fearon M, Jamieson F et al. (2003) Incidence of respiratory pathogens in patients with fever and respiratory symptoms during a SARS epidemic. In: Abstracts of the 43rd Infectious Disease Society of America Conference, San Diego, California, October 7-13, Abstract no. LB-16